Cite
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.
MLA
Vilariño-Güell, Carles, et al. “Exome Sequencing in Multiple Sclerosis Families Identifies 12 Candidate Genes and Nominates Biological Pathways for the Genesis of Disease.” PLoS Genetics, vol. 15, no. 6, June 2019, pp. 1–40. EBSCOhost, https://doi.org/10.1371/journal.pgen.1008180.
APA
Vilariño-Güell, C., Zimprich, A., Martinelli-Boneschi, F., Herculano, B., Wang, Z., Matesanz, F., Urcelay, E., Vandenbroeck, K., Leyva, L., Gris, D., Massaad, C., Quandt, J. A., Traboulsee, A. L., Encarnacion, M., Bernales, C. Q., Follett, J., Yee, I. M., Criscuoli, M. G., Deutschländer, A., & Reinthaler, E. M. (2019). Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease. PLoS Genetics, 15(6), 1–40. https://doi.org/10.1371/journal.pgen.1008180
Chicago
Vilariño-Güell, Carles, Alexander Zimprich, Filippo Martinelli-Boneschi, Bruno Herculano, Zhe Wang, Fuencisla Matesanz, Elena Urcelay, et al. 2019. “Exome Sequencing in Multiple Sclerosis Families Identifies 12 Candidate Genes and Nominates Biological Pathways for the Genesis of Disease.” PLoS Genetics 15 (6): 1–40. doi:10.1371/journal.pgen.1008180.